Adicet Bio, Inc.
ACET
$6.47
-$0.26-3.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.27% | 2.43% | 13.59% | 16.08% | 17.90% |
| Total Depreciation and Amortization | -1.35% | -0.05% | -0.56% | 0.03% | 6.07% |
| Total Amortization of Deferred Charges | 10.26% | -62.50% | -63.41% | -71.15% | 30.00% |
| Total Other Non-Cash Items | -42.51% | -56.51% | -63.76% | -53.94% | -44.17% |
| Change in Net Operating Assets | 126.66% | 79.43% | 54.95% | -45.39% | -2,292.46% |
| Cash from Operations | -3.10% | -7.27% | -7.85% | -2.65% | 1.43% |
| Capital Expenditure | -55.46% | -78.48% | -33.67% | 14.96% | 74.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.50% | 127.79% | -- | -- | -- |
| Cash from Investing | 102.01% | 125.51% | -5,497.54% | -4,271.02% | -2,571.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -32.26% | -99.64% | -99.64% | -99.69% | 28,772.54% |
| Repurchase of Common Stock | 26.24% | 53.15% | 62.99% | 62.99% | 6.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.40% | -99.87% | -99.73% | -99.79% | 47,063.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.45% | 5.52% | -1,101.91% | -1,457.78% | -2.42% |